Company Search:
Advanced Search
Sponsored Links
C21 Investments Inc Company Snapshot
C21 Investments Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares C21 Investments Inc with three other pharmaceutical manufacturers in North America: Nutralife Biosciences Inc of the United States (2012 sales of $126,576.00 ), Pharmacyte Biotech Inc of the United States ($66,558.00 of which 100% was Health & Nutritional Products), and Genufood Energy Enzymes Corp which is also based in the United States ($60,993.00 ).

Sales Analysis. C21 Investments Inc reported sales of C$132,677.00 (US$100.21 thousand) for the fiscal year ending January of 2012. This represents a decrease of 7.3% versus 2011, when the company's sales were C$143,160.00 .
  Stock Performance Chart for C21 Investments Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/8/2019): 1.08
(Figures in Canadian Dollars)
1 Week -5.3%   13 Weeks 30.1%  
4 Weeks 2.9%   52 Weeks n/a  
C21 Investments Inc Key Data:
  Ticker: CXXI Country: Canada
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2012 Sales 132,677
(Year Ending Jan 2013).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 48,669,601
  Fiscal Yr Ends: January Shares Outstanding: 45,064,445
  Share Type: Common Closely Held Shares: 17,360,904
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.